Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q3 2015 · 10-Q
Revenue$0.00$0.00— vs Q3 2014 Net Income-$348.52K-$348.52KN/M vs Q3 2014 EPS Diluted$0.00$0.00— vs Q3 2014 Operating Income-$322,806N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$182,176— ended Sep 30, 2015 · filed Nov 5, 2015 · 36 d after period end